- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 48.65M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 47.61M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 47.2M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $693K |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.64M |
| Capex | Q1 2025 · Mar 31, 2025 | $6.51M |
| Capex | Q1 2025 · Mar 31, 2024 | $8.29M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $4.63M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$39M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $171.86M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $196.52M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $116.85M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $161.06M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$420.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$373.24M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$184.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$122.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $480.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $473.97M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.09B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.07B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $423.72M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $445.09M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $666.46M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $692.46M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.01 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.30 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.30 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $5.92M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $8.4M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$48.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$61.47M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$22.79M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$38.1M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | −$13.95M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | −$27.68M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $350.11M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $321.72M |
| Revenue | Q1 2025 · Mar 31, 2025 | $336.16M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $294.05M |